CollPlant Biotechnologies Ltd.
- CLGN
- NASDAQ
- Biotechnology
- 3D Bioprinting
- Regenerative Medicine
- Medical Aesthetics
$3.53
Today −2.62%Quote Oct 19, 2026, 04:57 PM UTC
−12.86%over the last month
Max drawdown −25.7%From 1-month high −20.5%3 months +16.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About CollPlant Biotechnologies
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
39
Market value
$45.2M
Quote Oct 19
Floor
$3.50
0.7% below price
Resistance
$3.64
3.1% above price
Price vs analyst targets
5 analysts
Lowest target
$11.00Highest target
$14.00
$11.00Highest target
$14.00
- Price $3.53
- Average target $12.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 254% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CLGNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free